Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-023007

Options or other derivatives

  • Director acquired 15,342 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bronstein Ben Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +13,534 13,534 D
Bronstein Ben Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +875 875 D
Bronstein Ben Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +933 933 D
Loading xslF345X03/doc4.xml…